Artificial intelligence in autoimmune bullous dermatoses.

Area of Science:

• Dermatology
• Medical Informatics
• Artificial Intelligence

Background:

• Autoimmune bullous dermatoses (AIBDs) present complex challenges for dermatologists and patients throughout the care continuum.
• Current management involves difficulties in assessment, diagnosis, prognosis, treatment, and monitoring.
• There is a need for innovative solutions to improve patient outcomes and clinical workflows.

Purpose of the Study:

• To summarize the current and potential future clinical applications of artificial intelligence (AI) in the management of AIBDs.
• To explore how AI can enhance various stages of AIBD care, from diagnosis to follow-up.
• To highlight AI's role in supporting clinicians and patients in managing chronic skin diseases.

Main Methods:

• Review of recent research and existing AI models relevant to AIBDs.
• Analysis of AI applications in clinical diagnosis, disease severity scoring, and laboratory testing.
• Discussion of AI's potential impact on personalized treatment and patient management.

Main Results:

• AI, particularly image recognition, shows promise for precise clinical diagnosis and consistent disease severity scoring in AIBDs.
• AI-assisted laboratory methods could increase accuracy and reduce the time and cost of diagnostic tests like immunofluorescence.
• AI tools are emerging as valuable support systems for comprehensive diagnosis and personalized treatment of AIBDs.

Conclusions:

• AI applications are in early stages but demonstrate potential to significantly advance AIBD care.
• AI can enhance diagnostic accuracy, treatment personalization, and efficiency in managing AIBDs.
• AI may herald a transformative shift in managing chronic skin diseases, including AIBDs.